Abstract:Over 13 million people worldwide are affected by acute kidney injury (AKI), or the rapid reduction of renal function over a short period of time. Causes of AKI include genetics, nephrotoxic drugs, and medical interventions, when combined with lack of prevention and treatment interventions results in a death rate of 300,000/year. MicroRNAs (miRs) are thought to regulate apoptotic and inflammatory processes involved with AKI primarily through suppressing gene expression. Thus, miR expression profiles could serve as viable AKI biomarkers. Our goal was to identify miRs that are altered in kidney cortex tissue, urine, and plasma samples following renal ischemia-reperfusion injury (IRI). We hypothesized that in the 24 hours following IRI, alterations in miR abundance in the kidney would be reflected by similar or inverse changes in clinically accessible measured bio-fluids (urine and plasma), and that miRs altered in those bio-fluid samples would overlap. AKI was induced in 10-wk-old male Sprague Dawley rats by bilaterally clamping both the renal artery and vein for 30 mins, followed by 24 hrs of reperfusion (n=7). Sham surgeries were performed without vessel occlusion (n=5). Upon surgical recovery, rats were placed in metabolic cages for 24-hour urine collection. Blood, urine, and kidneys were collected and processed for blood assays, small RNA library preparation and sequencing following the 24-hour period. Small RNA sequencing results were analyzed using EdgeR2 to evaluate differential expression (DE) based on Benjamini-Hochberg adjusted p-value (p.adj) ≤ 0.05. An extensive literary search was performed to identify DE miRs involvement in AKI based on renal IRI models.Blood panel results show SCr (IR: 3.8 vs sham: 0.32mg/dL) and BUN (IR: 96.57 vs sham: 17.60mg/dL) were elevated in renal IRI male rats (p< 0.05). The miRNA seq data assayed 528 miRs, 174 were differentially altered in the cortical, urinary, and plasma samples (p.adj ≤ 0.05) following renal IRI. DE miRs in only 1 sample: 53 cortex-specific (10↑, 43↓); 50 plasma-specific (20↑, 30↓) and 27 urine-specific (16↑, 11↓). In total, 19 DE miRs were common to 2 sample types: 5 in plasma and urine samples, 8 in cortex and plasma samples; 6 in cortex and urine samples; 2 miRs in all three. Of the 21 overlapped DE miRs, 9 are associated with AKI pathology in published literature.AKI presents economic and clinical burdens that call for novel biomarkers of disease pathology that facilitate earlier treatment interventions. Using a clinically relevant AKI IR rat model, we observed that 11% of total DE miRs identified were common to 2 sample types and only 1% were common to all three. Future directions call for understanding miR abundance levels in circulation while also determining miR origin. This project highlights the need for more comprehensive analysis of miRs that are proposed as clinically relevant biomarkers of disease pathology that are representative of both the primary insult and circulation. The project described was supported by Award Number 2T32HL007852. The content is solely the responsibilities of the authors and does not necessarily represent the official views of the NIH. This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Implications of Dynamic Changes in Mir-192 Expression in Ischemic Acute Kidney Injury

Liquid Biopsies Poorly Mirror Renal Ischemia-Reperfusion Injury

Urinary MicroRNA-30c-5p and MicroRNA-192-5p As Potential Biomarkers of Ischemia-Reperfusion-induced Kidney Injury

Limited overlap between plasma, renal, and urinary microRNAs altered by ischemia reperfusion-induced Acute Kidney Injury (AKI)

MicroRNA expression profiling in acute kidney injury

Expression of Mirna-92A Affected by Renal Ischemia/reperfusion Injury in Mice

Concordant Changes of Plasma and Kidney MicroRNA in the Early Stages of Acute Kidney Injury: Time Course in a Mouse Model of Bilateral Renal Ischemia-Reperfusion

Os003 ipc reduces iri in the rat kidney byrepressing its unique microrna expression profile

Expression Of Mirna-210 And Mirna-92a Affected By Renal Ischemia/Reperfusion Injury In Mice

Discovery of mmu-lncRNA129814/hsa-lncRNA582795 as a Potential Biomarker and Intervention Target for Ischemia Reperfusion Injury-Induced AKI

Mir-124/ire-1 Affects Renal Ischemia/Reperfusion Injury by Regulating Endoplasmic Reticulum Stress in Renal Tubularepithelial Cells

The Expression Profile of Micrornas in Ischemic Kidney in Mice

Effects of Renal Ischemia on Micrornas and VEGF-NOTCH Signal Moleculars in Mice

Abstract 12855: Circulating miRNA-30a, -30e, -188 as Early Biomarkers for CI-AKI diagnosis

Role of Microrna in the Detection, Progression, and Intervention of Acute Kidney Injury

Circulating MicroRNA-188, -30a, and -30e as Early Biomarkers for Contrast-Induced Acute Kidney Injury.

MicroRNA-216a-5p Alleviates Acute Kidney Injury of Mice via Suppressing FAS Ligand Expression

Mir-21 in Ischemia/reperfusion Injury: a Double-Edged Sword?

Supplementary Material For: Mir-874-3p is Identified As a Biomarker for Acute Kidney Injury and Mediates Disease Development Via Targeting MSRB3

Identification of biomarkers, immune infiltration landscape, and treatment targets of ischemia–reperfusion acute kidney injury at an early stage by bioinformatics methods

Integrated Analysis of Gene Expression and Immune Cell Infiltration Reveals Dysregulated Genes and miRNAs in Acute Kidney Injury